Ignite Creation Date:
2024-05-06 @ 12:59 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03900949
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2019-04-01
Brief Title:
Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia
Sponsor:
Uma Borate
Organization:
Ohio State University Comprehensive Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-01
First Submit QC Date:
April 1 2019
Study First Post Date:
2019-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-09
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL